Company Monitoring Page for Actelion

latest headlines for company on cafepharma

Actelion’s Hiring of Goldman May Lead to Sale, Vontobel Says
Bloomberg
Fri, 03/18/11 - 09:02 am
Tags:
Actelion, M&A
Actelion On The Defensive: Corporate Governance White Paper
InVivo
Thu, 03/10/11 - 12:02 pm
Tags:
Actelion
Top Biotech Takeout Targets in 2011
Minyanville
Fri, 02/18/11 - 03:32 pm
Tags:
M&A, biotech, Biogen Idec, Human Genome, Seattle Genetics, GSK, Dendreon, Actelion, Biomarin, Exelixis, Vertex Pharmaceuticals, Celgene, Alexion, Shire, InterMune, Lexicon Pharmaceuticals, Savient, Merck KGaA
Jury Nails J&J With $482 Million Patent Infringement Verdict: Biotech's Latest Tribulations
Seeking Alpha
Mon, 02/7/11 - 08:01 am
Tags:
JNJ, GSK, Pfizer, Teva Pharmaceuticals, Actelion
Actelion Boss Won’t Give Up Without a Fight
WSJ Online
Fri, 02/4/11 - 11:07 am
Tags:
Actelion
Actelion Enters Evel Knievel Territory
WSJ Online
Mon, 01/31/11 - 11:51 am
Tags:
Actelion, Tracleer, PAH
How GlaxoSmithKline Lost $635M in Bad Bets on Sleeping Pills
BNET Pharma
Fri, 01/28/11 - 12:14 pm
Tags:
GSK, insomnia, Actelion, almorexant, Lunesta, Sunovion
Amgen, Actelion Talk but No Offer Made
TheStreet.com
Mon, 12/13/10 - 10:13 am
Tags:
Amgen, Actelion, M&A
Actelion Wants to Remain Independent, CEO Clozel Says
Bloomberg
Sat, 12/11/10 - 10:49 am
Tags:
M&A, Amgen, Actelion
Actelion Takeover: Constant Speculation, Doubts Linger
Seeking Alpha
Mon, 11/29/10 - 09:04 am
Tags:
M&A, Abbott Laboratories, Actelion, GSK, JNJ, Roche, Amgen, Bristol-Myers Squibb
Amgen Holder Invesco Says Potential Actelion Deal Not `Hugely Compelling'
Bloomberg
Tue, 11/23/10 - 10:49 am
Tags:
Amgen, M&A, Actelion
Actelion: Genzyme-Sanofi Redux?
WSJ Online
Mon, 11/22/10 - 10:32 am
Tags:
Genzyme, Actelion, Sanofi, M&A, Bayer, Amgen, AstraZeneca
Actelion, Eyed by Amgen, May Fetch $9.8 Billion in Takeover, Analysts Say
Bloomberg
Thu, 11/18/10 - 07:58 am
Tags:
Actelion, Amgen, M&A
Actelion shares surge (again) as M&A buzz hits fever pitch
Fierce Biotech
Wed, 11/17/10 - 11:46 am
Tags:
Actelion, M&A, Amgen
Actelion Sets $827 Million Share Repurchase as Takeover Speculation Swirls
Bloomberg
Thu, 10/21/10 - 10:48 am
Tags:
Actelion, share repurchase, M&A, earnings
Novartis Halts Development of Two Drugs: Biotech's Latest Tribulations
Seeking Alpha
Mon, 10/11/10 - 11:20 am
Tags:
Novartis, Actelion, AstraZeneca, Human Genome, JNJ, ONYX Pharmaceuticals, Pfizer, Rosetta Genomics, Targacept, Mycograb, albinterferon alfa-2b
Actelion Surges on Report It May Be Weighing Selling Itself
Bloomberg
Fri, 10/8/10 - 08:09 am
Tags:
Actelion, M&A, GSK, Roche, Amgen, Bristol-Myers Squibb
FDA Slams Actelion Amid BMS Buyout Rumors
Motley Fool
Thu, 10/7/10 - 06:03 pm
Tags:
Bristol-Myers Squibb, FDA, Actelion, M&A, Tracleer, Ventavis
Actelion Pharma Failed To Report 3,500 Deaths
Pharmalot
Thu, 10/7/10 - 11:49 am
Tags:
Actelion, FDA, adverse events, Tracleer, Ventavis
FDA Warns Actelion Unit On Post-Marketing Drug Report Failures
WSJ Online
Tue, 10/5/10 - 11:12 am
Tags:
FDA, Actelion, post-marketing data, Tracleer, Ventavis, PAH

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.